Quercetin Alleviates Menstrual Disorders and Uterine Inflammation via Regulating PRLR/GHR and the JAK2-STAT Pathway: Evidence from Network Pharmacology Combined with Proteomics

This study investigated the effects of quercetin (QU) on reproductive endocrine and uterine parameters in a rat model of reproductive endocrine disturbance and explored potential mechanisms. The model was established by co-administering hydrocortisone and thyroxine, with model status assessed by general health indicators. Rats were divided into normal, model, Dingkundan, QU high-dose, and QU low-dose groups. Network pharmacology predicted overlapping targets/pathways between QU and irregular menstruation, and the model was used to mimic this clinical condition, followed by KEGG enrichment. Uterine proteomics identified candidate differential pathways for comparison with network predictions. ELISA measured hypothalamic GnRH, pituitary FSH, ovarian E2, inflammatory and immunoregulatory cytokines (TGF-β, IL-10, IL-6, IL-1β), and uterine COX-2, MPO, GSH, HO-1, and total NRF2. PRLR and GHR expression in uterus and ovary were detected by immunofluorescence, along with uterine p-JAK2, p-STAT3, and p-STAT5. Histopathology was assessed via H&E staining. Both network pharmacology and proteomic KEGG enrichment analyses highlighted pathways associated with hormones and with JAK/STAT signaling. Compared with the model group, QU significantly increased GnRH, FSH, and E2. In addition, QU reduced IL-6 and IL-1β, with concomitant decreases in IL-10 and TGF-β. QU also reduced COX-2 and MPO while elevating GSH, HO-1, and total NRF2. Moreover, QU attenuated PRLR and enhanced GHR fluorescence. Finally, QU significantly downregulated STAT3/STAT5 phosphorylation, with a non-significant trend for p-JAK2. Histopathological damage was alleviated. QU treatment was associated with improved reproductive hormone levels and attenuated uterine histopathological damage, inflammation, and oxidative stress markers. These effects were accompanied by PRLR downregulation, GHR upregulation, and reduced STAT3/STAT5 phosphorylation.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-18
DOI
https://doi.org/10.3390/ijms272210363
Primary Topic
Estrogen and related hormone effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Quercetin Alleviates Menstrual Disorders and Uterine Inflammation via Regulating PRLR/GHR and the JAK2-STAT Pathway: Evidence from Network Pharmacology Combined with Proteomics

Jinhu Chen, Jinnan Zhao, Yinglin Liu, Yi-Hao Che et al.
International Journal of Molecular Sciences
Estrogen and related hormone effects
article

Quercetin Alleviates Menstrual Disorders and Uterine Inflammation via Regulating PRLR/GHR and the JAK2-STAT Pathway: Evidence from Network Pharmacology Combined with Proteomics

Jinhu Chen, Jinnan Zhao, Yinglin Liu, Yi-Hao Che, Heng Liu, Ting Su, Ai Zhu, Xiao-Xue Wen
article en

Abstract

This study investigated the effects of quercetin (QU) on reproductive endocrine and uterine parameters in a rat model of reproductive endocrine disturbance and explored potential mechanisms. The model was established by co-administering hydrocortisone and thyroxine, with model status assessed by general health indicators. Rats were divided into normal, model, Dingkundan, QU high-dose, and QU low-dose groups. Network pharmacology predicted overlapping targets/pathways between QU and irregular menstruation, and the model was used to mimic this clinical condition, followed by KEGG enrichment. Uterine proteomics identified candidate differential pathways for comparison with network predictions. ELISA measured hypothalamic GnRH, pituitary FSH, ovarian E2, inflammatory and immunoregulatory cytokines (TGF-β, IL-10, IL-6, IL-1β), and uterine COX-2, MPO, GSH, HO-1, and total NRF2. PRLR and GHR expression in uterus and ovary were detected by immunofluorescence, along with uterine p-JAK2, p-STAT3, and p-STAT5. Histopathology was assessed via H&E staining. Both network pharmacology and proteomic KEGG enrichment analyses highlighted pathways associated with hormones and with JAK/STAT signaling. Compared with the model group, QU significantly increased GnRH, FSH, and E2. In addition, QU reduced IL-6 and IL-1β, with concomitant decreases in IL-10 and TGF-β. QU also reduced COX-2 and MPO while elevating GSH, HO-1, and total NRF2. Moreover, QU attenuated PRLR and enhanced GHR fluorescence. Finally, QU significantly downregulated STAT3/STAT5 phosphorylation, with a non-significant trend for p-JAK2. Histopathological damage was alleviated. QU treatment was associated with improved reproductive hormone levels and attenuated uterine histopathological damage, inflammation, and oxidative stress markers. These effects were accompanied by PRLR downregulation, GHR upregulation, and reduced STAT3/STAT5 phosphorylation.

International Journal of Molecular SciencesVol. 27(22)
Dali University (CN)
Good health and well-being
Estrogen and related hormone effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon